NTHI

Latest SEC Filings & News for NTHI

2 most recent filings and news items mentioning NTHI. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/NTHI/news?limit=20"

Pull NTHI filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJul 15, 2026Positive

NeOnc receives FDA feedback on NEO212 tablet transition

NeOnc Technologies received detailed FDA feedback regarding the Chemistry, Manufacturing and Controls for its NEO212 candidate, including actionable steps for a tablet formulation transition. The constructive guidance allows the company to proceed with a staged stability program,

View filing at SEC.gov →

RegulatoryJun 23, 2026Positive

DOH grants UAE IND for NeOnc's lead candidate NEO100

NeOnc Technologies received UAE IND approval for its lead candidate NEO100 across multiple dosing protocols. This authorization complements recent UAE clearance for NEO212 and precedes the imminent Phase 2a data readout in July.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.